mutations and complex kar yotype. It follows a linear evolution through the CLL clone in the recurrent acquisition of CDKN2A Not all people with CLL call for therapy. In spite of all current innovations, the iwCLL however suggests watchful observation for patients with asymptomatic disorder.86 Th